Evaluation of protective efficacy of respiratory syncytial virus vaccine against A and B subgroup human isolates in Korea

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Jang, Ji Eun ^a   Lee, Jee Boong ^a   Kim, Kyung Hyo ^b   Park, Sung Moo ^c   Shim, Byoung Shik ^c   Cheon, In Soo ^c   Song, Man Ki ^c   Chang, Jun ^a  

^a Ewha Womans University   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

^c International Vaccine Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NUCLEOTIDE; RESPIRATORY SYNCYTIAL VIRUS VACCINE; THROMBOSPONDIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CROSS PROTECTION; CYTOPATHOGENIC EFFECT; DRUG EFFICACY; FEMALE; GENE; GENE AMPLIFICATION; GENE DELETION; GENE DUPLICATION; GENE SEQUENCE; GENETIC VARIABILITY; GLYCOPROTEIN G GENE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNIZATION; LIMIT OF DETECTION; LOWER RESPIRATORY TRACT INFECTION; MOUSE; NASOPHARYNGEAL ASPIRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHYLOGENETIC TREE; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SINGLE DRUG DOSE; SOUTH KOREA; VIRUS ISOLATION; VIRUS RECOMBINANT; VIRUS REPLICATION; ANIMAL; BAGG ALBINO MOUSE; CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOLOGY; INFANT; INTRANASAL DRUG ADMINISTRATION; LUNG; MALE; NEWBORN; PATHOGENICITY; PATHOLOGY; PHYLOGENY; PRESCHOOL CHILD; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIROLOGY;

ADENOVIRIDAE; HUMAN RESPIRATORY SYNCYTIAL VIRUS; HYDRANGEA RINGSPOT VIRUS; MUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

ADMINISTRATION, INTRANASAL; ANIMALS; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LUNG; MALE; MICE; MICE, INBRED BALB C; PHYLOGENY; REPUBLIC OF KOREA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUSES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 80052544139     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023797     Document Type: Article

References (30)

1. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE, (2005) Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 352: 1749-1759.
2. Murata Y, Falsey AR, (2007) Respiratory syncytial virus infection in adults. Antivir Ther 12: 659-670.
3. Tregoning JS, Schwarze J, (2010) Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev 23: 74-98.
4. Sampalis JS, (2003) Morbidity and mortality after RSV-associated hospitalizations among premature Canadian infants. J Pediatr 143: S150-156.
5. Falsey AR, (2007) Respiratory syncytial virus infection in adults. Semin Respir Crit Care Med 28: 171-181.
6. Han LL, Alexander JP, Anderson LJ, (1999) Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis 179: 25-30.
7. Martinez FD, (2003) Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma. Pediatr Infect Dis J 22: S76-82.
8. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, (2000) Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 161: 1501-1507.
9. Openshaw PJ, Dean GS, Culley FJ, (2003) Links between respiratory syncytial virus bronchiolitis and childhood asthma: clinical and research approaches. Pediatr Infect Dis J 22: S58-64; discussion S64-55.
10. Sigurs N, Gustafsson PM, Bjarnason R, Lundberg F, Schmidt S, et al. (2005) Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 171: 137-141.
11. Henderson FW, Collier AM, Clyde WA Jr, Denny FW, (1979) Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N Engl J Med 300: 530-534.
12. Glezen WP, Taber LH, Frank AL, Kasel JA, (1986) Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 140: 543-546.
13. Hall CB, Walsh EE, Long CE, Schnabel KC, (1991) Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 163: 693-698.
14. Yu JR, Kim S, Lee JB, Chang J, (2008) Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection. J Virol 82: 2350-2357.
15. Nagai K, Kamasaki H, Kuroiwa Y, Okita L, Tsutsumi H, (2004) Nosocomial outbreak of respiratory syncytial virus subgroup B variants with the 60 nucleotides-duplicated G protein gene. J Med Virol 74: 161-165.
16. Trento A, Galiano M, Videla C, Carballal G, Garcia-Barreno B, et al. (2003) Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides. J Gen Virol 84: 3115-3120.
17. Agoti CN, Mbisa JL, Bett A, Medley GF, Nokes DJ, et al. (2010) Intrapatient variation of the respiratory syncytial virus attachment protein gene. J Virol 84: 10425-10428.
18. Choi EH, Lee HJ, (2000) Genetic diversity and molecular epidemiology of the G protein of subgroups A and B of respiratory syncytial viruses isolated over 9 consecutive epidemics in Korea. J Infect Dis 181: 1547-1556.
19. Semple MG, Cowell A, Dove W, Greensill J, McNamara PS, et al. (2005) Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J Infect Dis 191: 382-386.
20. Galiano MC, Palomo C, Videla CM, Arbiza J, Melero JA, et al. (2005) Genetic and antigenic variability of human respiratory syncytial virus (groups a and b) isolated over seven consecutive seasons in Argentina (1995 to 2001). J Clin Microbiol 43: 2266-2273.
21. Garcia O, Martin M, Dopazo J, Arbiza J, Frabasile S, et al. (1994) Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein. J Virol 68: 5448-5459.
22. Cane PA, Pringle CR, (1995) Evolution of subgroup A respiratory syncytial virus: evidence for progressive accumulation of amino acid changes in the attachment protein. J Virol 69: 2918-2925.
23. Coggins WB, Lefkowitz EJ, Sullender WM, (1998) Genetic variability among group A and group B respiratory syncytial viruses in a children's hospital. J Clin Microbiol 36: 3552-3557.
24. Peret TC, Hall CB, Schnabel KC, Golub JA, Anderson LJ, (1998) Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol 79 (Pt 9): 2221-2229.
25. Anderson LJ, Hierholzer JC, Tsou C, Hendry RM, Fernie BF, et al. (1985) Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis 151: 626-633.
26. Johnson PR, Spriggs MK, Olmsted RA, Collins PL, (1987) The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc Natl Acad Sci U S A 84: 5625-5629.
27. Melero JA, Garcia-Barreno B, Martinez I, Pringle CR, Cane PA, (1997) Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein. J Gen Virol 78 (Pt 10): 2411-2418.
28. Rueda P, Delgado T, Portela A, Melero JA, Garcia-Barreno B, (1991) Premature stop codons in the G glycoprotein of human respiratory syncytial viruses resistant to neutralization by monoclonal antibodies. J Virol 65: 3374-3378.
29. Graham BS, (2011) Biological challenges and technological opportunities for respiratory syncytial virus vaccine development. Immunol Rev 239: 149-166.
30. Chang J, (2011) Current progress on development of respiratory syncytial virus vaccine. BMB Rep 44: 232-237.